These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8700804)

  • 1. Effects of finasteride on health-related quality of life in men with symptomatic benign prostatic hyperplasia. Finasteride Study Group.
    Girman CJ; Kolman C; Liss CL; Bolognese JA; Binkowitz BS; Stoner E
    Prostate; 1996 Aug; 29(2):83-90. PubMed ID: 8700804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Finasteride in the treatment of benign prostatic hyperplasia.
    Ekman P; Andersen JT; Wolf H
    Acta Urol Belg; 1996 Mar; 64(1):IX-XII. PubMed ID: 8659328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of benign prostatic hyperplasia with Proscar (finasteride). Results of a 10-year Scandinavian study].
    Tveter KJ; Beisland HO; Andersen JT; Wolf H; Ekman P; Johansson JE; Kontturi M; Lehtonen T
    Tidsskr Nor Laegeforen; 1996 Nov; 116(27):3226-30. PubMed ID: 9011975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, tolerability, and effect on health-related quality of life of finasteride versus placebo in men with symptomatic benign prostatic hyperplasia: a community based study. CUSP Investigators. Community based study of Proscar.
    Byrnes CA; Morton AS; Liss CL; Lippert MC; Gillenwater JY
    Clin Ther; 1995; 17(5):956-69. PubMed ID: 8595647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Finanseride in symtomatic benign prostatic hyeprtrophy. A 2-year placebo-controlled study].
    Andersen JT; Wolf H; Ekman P; Beisland HO; Johansson JE; Kontturi M; Lehtonen T; Tveter K
    Ugeskr Laeger; 1996 Sep; 158(36):5030-5. PubMed ID: 8928243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasia.
    Roehrborn CG; Bruskewitz R; Nickel JC; McConnell JD; Saltzman B; Gittelman MC; Malek GH; Gottesman JE; Suryawanshi S; Drisko J; Meehan A; Waldstreicher J;
    J Urol; 2004 Mar; 171(3):1194-8. PubMed ID: 14767299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Benign prostatic hyperplasia: patients' perception of medical treatment and their expectations. Results of a french survey involving patients treated with finasteride].
    Teillac P
    Therapie; 2002; 57(5):473-83. PubMed ID: 12611202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial.
    Johnson TM; Jones K; Williford WO; Kutner MH; Issa MM; Lepor H
    J Urol; 2003 Jul; 170(1):145-8. PubMed ID: 12796667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of finasteride on bother and other health-related quality of life aspects associated with benign prostatic hyperplasia. PLESS Study Group. Proscar Long-term Efficacy and Safety Study.
    Bruskewitz R; Girman CJ; Fowler J; Rigby OF; Sullivan M; Bracken RB; Fusilier HA; Kozlowski D; Kantor SD; Johnson EL; Wang DZ; Waldstreicher J
    Urology; 1999 Oct; 54(4):670-8. PubMed ID: 10510926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of men with clinical benign prostatic hyperplasia treated with alfuzosin by general practitioners: 1-year results.
    Lukacs B; Leplège A; Thibault P; Jardin A
    Urology; 1996 Nov; 48(5):731-40. PubMed ID: 8911517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dutasteride significantly improves quality of life measures in patients with enlarged prostate.
    O'Leary MP; Roehrborn CG; Black L
    Prostate Cancer Prostatic Dis; 2008; 11(2):129-33. PubMed ID: 17592479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative evaluation of the effectiveness and safety of combined drug therapy of patients with benign prostatic hyperplasia with finasteride and alfuzozine].
    Loran OB; Pushkar' DIu; Rasner PI
    Urologiia; 2002; (1):19-22. PubMed ID: 11877966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Finasteride in the treatment of patients with moderate symptoms of benign prostatic hyperplasia.
    Magoha GA
    East Afr Med J; 1998 May; 75(5):260-3. PubMed ID: 9746993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
    Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T
    Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finasteride following balloon dilatation of the prostate. A double-blind, placebo-controlled, multicenter study.
    Lukkarinen O; Lehtonen T; Talja M; Lundstedt S; Tiitinen J; Taari K
    Ann Chir Gynaecol; 1999; 88(4):299-303. PubMed ID: 10661828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of finasteride in symptomatic benign prostatic hyperplasia: a primary care study. Primary Care Investigator Study Group.
    Tenover JL; Pagano GA; Morton AS; Liss CL; Byrnes CA
    Clin Ther; 1997; 19(2):243-58. PubMed ID: 9152564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term results of proscar (finasteride, MSD) treatment of patients with benign prostatic hyperplasia].
    Tkachuk VN; Al'-Shukri SKh; Kornienko VI; Kuz'min IV
    Urol Nefrol (Mosk); 1998; (4):37-9. PubMed ID: 9727320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the efficacy and tolerability of tamsulosin and finasteride in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Rigatti P; Brausi M; Scarpa RM; Porru D; Schumacher H; Rizzi CA;
    Prostate Cancer Prostatic Dis; 2003; 6(4):315-23. PubMed ID: 14663474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Finasteride: new indication. Benign prostatic hypertrophy: sexual disorders.
    Prescrire Int; 2007 Aug; 16(90):147. PubMed ID: 17724838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medical treatment of benign prostatic hyperplasia. The efficacy of finasteride depends on prostatic volume].
    Granados Loarca EA
    Arch Esp Urol; 1999 Apr; 52(3):201-8. PubMed ID: 10371735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.